Highlights AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:02 2025-12-16 EST			5-day change	1st Jan Change
223.67 ^USD	-1.66%		+0.30%	+25.87%

12-15	RedHill Biopharma Ltd.'s Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells	CI
12-15	AbbVie's Upside Potential Limited in Pipeline-Light 2026, BofA Securities Says	MT

Highlights

RedHill Biopharma Ltd.'s Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells	12-15	CI
OSE Immunotherapeutics SA Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development	12-08	CI
AbbVie to Feature New Data At ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers	12-02	CI
Amneal Announces U.S. Fda Approval of Cyclosporine Ophthalmic Emulsion 0.05%	12-01	CI
Abbvie to Present Phase 3 Eclipse Data Demonstrating Atogepant (Aquipta®?) Superiority over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine At the 19Th European Headache Congress	12-01	CI
AbbVie Corporation Announces Two Positive Updates for Canadians Living with Ulcerative Colitis	11-28	CI
Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices	11-26	MT
Major deals involving U.S. drugmakers and biotechs over the past decade	11-20	RE
US FDA approves Bayer drug for specific type of lung cancer	11-19	RE
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma	11-18	CI
Sector Update: Health Care Stocks Rise Late Afternoon	11-18	MT
Traders Strap In, Again	11-18
Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET	11-17	RE
Abbvie Announces New 6-Month 45Mg Luprolide Acetate for Extended-Release Injectable Suspension	11-17	CI
Mesoblast Limited Appoints James M. O?Brien as Chief Financial Officer	11-17	CI
AbbVie Inc. Announces Launch of Second Winds	11-14	CI
Sector Update: Health Care Stocks Rise Late Afternoon	11-12	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	11-12	MT
AbbVie Severs Ties With Google-Backed Aging Research Biotech, STAT+ Reports	11-12	MT
Immuthera and Its Wholly Owned Subsidiary of Poltreg S.A Appoints Adrian Bot to Its Board of Directors	11-07	CI
Prime Medicine Q3 net loss narrows	11-07	RE
Calico Life Sciences announces US FDA orphan drug designation for investigational treatment of autosomal dominant polycystic kidney disease	11-05	RE
Tranche Update on AbbVie Inc.'s Equity Buyback Plan announced on February 15, 2018.	11-04	CI
Sector Update: Health Care	10-31	MT
AbbVie says Trump pressing for larger Medicare drug price cuts	10-31	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Highlights

Filters